Thermochemical ablation of bodily tissue

• US 8,343,095 B2
• Filed: 02/21/2008
• Issued: 01/01/2013
• Est. Priority Date: 02/27/2007
• Status: Active Grant

• Current Assignee: Regents of The University of Minnesota (University of Minnesota)
• Original Assignee: Regents of The University of Minnesota (University of Minnesota)
• Inventors: Cressman, Erik N. K.
• Primary Examiner(s): KOHARSKI, CHRISTOPHER
• Application Number:
  US12/528,015
• Publication Number:
  US 20100145304A1
• Time in Patent Office: 1,776 Days
• Field of Search: 606/32, 606/41, 606/45, 604 82- 92
• US Class Current: 604/82
• CPC Class Codes: A61B 18/06 caused by chemical reaction , e.g. moxaburners
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 2018/068 none of the reactants being oxygen

Abstract

Thermochemical ablation techniques may provide ablation of bodily tissue using chemical reaction energy.

Claims

1. A thermochemical ablation system, comprising:

a percutaneous fluid delivery cannula comprising first and second lumens extending from a proximal portion to a distal portion, the distal portion comprising a first side port in fluid communication with at least the first lumen and a second side port in fluid communication with at least the second lumen;

a first reservoir that contains a first thermochemical ablation reagent so as to communicate the first thermochemical ablation reagent through the first lumen to the distal portion of the percutaneous fluid delivery cannula, at least a portion of the first thermochemical ablation reagent being deliverable out of the first side port; and

a second reservoir that contains a second thermochemical ablation reagent so as to communicate the second thermochemical ablation reagent through the second lumen to the distal portion of the percutaneous fluid delivery cannula, at least a portion of the second thermochemical ablation reagent being deliverable out of the second side port to provide simultaneous radial dispersion and mixing of the first and second thermochemical ablation reagents at the distal portion.

2. The system of claim 1, wherein when the first thermochemical ablation reagent is delivered from the first side port and the second thermochemical ablation reagent is delivered from the second side port, the first and second thermochemical ablation reagents mix with one another to generate an exothermic chemical reaction.

3. The system of claim 2, wherein the exothermic chemical reaction generates heat to ablate bodily tissue proximate the distal portion of the percutaneous fluid delivery cannula.

4. The system of claim 1, wherein the first thermochemical ablation reagent comprises an acid.

5. The system of claim 4, wherein the first thermochemical ablation reagent comprises an acid selected from the group consisting of acetic acid, peracetic acid, hydrochloric acid, hydrobromic acid, hydriodic acid, sulfuric acid, nitric acid, nitrous acid, perchloric acid, phosphoric acid, oxalic acid, pyruvic acid, malonic acid, and amino acids.

6. The system of claim 4, wherein the second thermochemical ablation reagent comprises a base.

7. The system of claim 6, wherein the second thermochemical ablation reagent comprises base selected from the group consisting of KOH, NaOH, NH₄OH, Ca(OH)₂, NaHCO₃, K₂CO₂, BuLi, NaOEt or NaSEt, NaH, KH, and amines.

8. The system of claim 1, wherein the first thermochemical ablation reagent comprises an electrophile selected from the group consisting of acetic anhydride, acetyl chloride, and acetyl bromide, and the second thermochemical ablation reagent comprises a nucleophile.

9. The system of claim 1, further comprising a first actuator to deliver fluid from the first reservoir and a second actuator to deliver fluid from the second reservoir, the first and second actuators being coupled to one another so as to provide simultaneous actuation.

10. The system of claim 1, wherein the percutaneous fluid delivery cannula comprises a generally rigid injection needle.

11. The system of claim 10, wherein the injection needle comprises an outside diameter of about 0.134 inches or less.

12. The system of claim 1, wherein the percutaneous fluid delivery cannula comprises a flexible catheter.

13. A device to ablate bodily tissue, comprising:

a multi-lumen thermochemical ablation cannula to simultaneously infuse at least two thermochemical ablation reagents into targeted tissue proximate a distal portion of the cannula;

the distal portion of the cannula comprising a plurality of exterior fluid exit ports to dispense at least two thermochemical ablation reagents and thereby mix the at least two thermochemical ablation reagents proximate a distal portion of the cannula,

wherein when the at least two thermochemical ablation reagents are dispensed from the plurality of exterior fluid exit ports, the thermochemical ablation reagents mix with one another to generate an exothermic chemical reaction sufficient to ablate tissue.

14. The device of claim 13, wherein the multi-lumen thermochemical ablation cannula is a dual lumen injection needle having a first lumen to deliver an acid reagent and second lumen to deliver a base reagent.

15. The device of claim 14, wherein the thermochemical ablation reagents mix with one another to generate an exothermic chemical reaction while at least partially neutralizing the acid load and base load.

16. A method for thermochemical ablation of targeted tissue, comprising:

delivering a first thermochemical ablation reagent through a first lumen of a percutaneous injection needle;

delivering a second thermochemical ablation reagent through a second lumen of the percutaneous injection needle; and

simultaneously infusing first and second thermochemical ablation reagents into targeted tissue to radially disperse and mix the first and second thermochemical ablation reagents at a distal portion of the injection needle wherein when the first thermochemical ablation reagent is delivered from a first side port of the injection needle and the second thermochemical ablation reagent is delivered from a second side port of the injection needle, the first and second thermochemical ablation reagents mixing with one another to generate an exothermic chemical reaction.

17. The method of claim 16, wherein the exothermic chemical reaction generates heat to ablate bodily tissue proximate the distal portion of the injection needle.

18. The method of claim 16, wherein the first thermochemical ablation reagent comprises an acid selected from the group consisting of acetic acid, peracetic acid, hydrochloric acid, hydrobromic acid, hydriodic acid, sulfuric acid, nitric acid, nitrous acid, perchloric acid, phosphoric acid, oxalic acid, pyruvic acid, malonic acid, and amino acids.

19. The method of claim 18, wherein the second thermochemical ablation reagent comprises a base selected from the group consisting of KOH, NaOH, NH₄OH, Ca(OH)₂, NaHCO₃, K₂CO₂, BuLi, NaOEt or NaSEt, NaH, KH, and amines.